Expert Discusses Promise of Immunotherapy in TNBC – OncLive
OncLive |
Expert Discusses Promise of Immunotherapy in TNBC
OncLive The combination of immunotherapy and chemotherapy is showing promising response rates in certain patients with triple-negative breast cancer (TNBC), said ESO Umberto Veronesi Memorial Award Winner Giuseppe Curigliano, MD, PhD, who addressed … |
